Dr. Reddy’s Laboratories launches Fluphenazine Hydrochloride Tablets in US

Dr. Reddy’s Laboratories launches Fluphenazine Hydrochloride Tablets in US

Dr. Reddy’s Laboratories, an Indian pharma company, has launched Fluphenazine Hydrochloride Tablets, USP, in the US market. Fluphenazine Hydrochloride Tablets, USP is a therapeutic equivalent generic version of Prolixin Tablets, 1 mg, 2.5 mg, 5 mg, and 10 mg, which has approval from the US Food and Drug Administration (FDA) for the management of manifestations […]